Study Makes MOVES For Chondroitin/Glucosamine On Osteoarthritis Pain
This article was originally published in The Tan Sheet
Executive Summary
At six months, 79.7% of the moderate-to-severe patients in the supplementation group and 79.2% in the celecoxib group fulfilled pain reduction criteria, the primary outcome measured in the Multicenter Osteoarthritis InterVEntion trial with SYSADOA.